{"0": {"lymphocytic leukemia": 0.6167362332344055, "leukemia": 0.5772315263748169, "chronic lymphocytic": 0.4601937234401703, "chronic": 0.3728301227092743, "cancer": 0.28818821907043457, "gene therapy": 0.2272173911333084, "relapsed refractory": 0.17232954502105713, "cell therapy": 0.17138272523880005, "relapsed": 0.16139185428619385, "treatment": 0.15468722581863403, "tg therapeutics": 0.13821740448474884, "cll": 0.13521738350391388, "patients aged": 0.13335852324962616, "therapy": 0.13017411530017853, "fda": 0.12170614302158356, "response": 0.11502201855182648, "refractory cll": 0.11232949048280716, "elderly patients": 0.11220142245292664, "patients": 0.10926613956689835, "jinxing": 0.09790138900279999, "blood": 0.08768446743488312, "dr": 0.08763265609741211, "jinxing capsule": 0.08578245341777802, "imbruvica": 0.08199140429496765, "trial": 0.08193732053041458, "lymphocytic": 0.0817682147026062, "clinical": 0.07974126189947128, "results": 0.07365509122610092, "ginsenoside rh": 0.06877528131008148, "will": 0.051876477897167206, "but": 0.04696277529001236, "rh": 0.04459042847156525, "my": 0.04316144436597824, "rituximab": 0.042601730674505234, "high": 0.04196177050471306, "cells": 0.04148778319358826, "you": 0.04066154360771179, "may": 0.04019477963447571, "refractory": 0.038259681314229965, "drug": 0.03761272504925728, "car cell": 0.03553009033203125, "can": 0.031560223549604416, "do": 0.030691023916006088, "venetoclax plus": 0.0299981776624918, "for": 0.026919957250356674, "efficacy": 0.02090013213455677, "long term": 0.020738720893859863, "will be": 0.019142286852002144, "ibrutinib": 0.0187040027230978, "study": 0.018694642931222916}, "1": {"relapsed refractory": 0.5016158223152161, "refractory cll": 0.3822818398475647, "relapsed": 0.37698450684547424, "refractory": 0.25472602248191833, "lymphocytic leukemia": 0.2500670552253723, "cll": 0.2016458511352539, "chronic lymphocytic": 0.19545462727546692, "cell therapy": 0.18349823355674744, "patients aged": 0.1606876254081726, "jinxing capsule": 0.15935492515563965, "leukemia": 0.15760380029678345, "gene therapy": 0.15018942952156067, "therapy": 0.14424946904182434, "venetoclax plus": 0.13994717597961426, "long term": 0.13530708849430084, "elderly patients": 0.12026918679475784, "chronic": 0.12026199698448181, "efficacy": 0.11769497394561768, "patients": 0.10989208519458771, "cancer": 0.10209866613149643, "fda": 0.09907850623130798, "treatment": 0.09642182290554047, "response": 0.0824398472905159, "tg therapeutics": 0.07104992866516113, "lymphocytic": 0.06357648968696594, "dr": 0.06069963797926903, "capsule": 0.057232752442359924, "ginsenoside rh": 0.05359770357608795, "rituximab": 0.05198367312550545, "ibrutinib": 0.048879224807024, "will": 0.047062259167432785, "imbruvica": 0.03897123411297798, "venetoclax": 0.03499536216259003, "results": 0.030185386538505554, "jinxing": 0.018090078607201576, "rh": 0.012343697249889374, "may": -0.0046086497604846954, "will be": -0.00890280306339264, "clinical": -0.011229971423745155, "abbvie": -0.014677206054329872, "cells": -0.02163664996623993, "years": -0.02297750674188137, "but": -0.024193836376070976, "risk": -0.024701442569494247, "more": -0.026046890765428543, "cell": -0.027061201632022858, "who": -0.02870849147439003, "data": -0.030950183048844337, "do": -0.031670838594436646, "can": -0.03191971778869629}, "2": {"dr": 0.45995163917541504, "cll": 0.3267691135406494, "gene therapy": 0.2544994354248047, "tg therapeutics": 0.23471379280090332, "fda": 0.19924697279930115, "chronic lymphocytic": 0.18981200456619263, "ginsenoside rh": 0.1864227056503296, "patients": 0.1569119393825531, "therapy": 0.15574043989181519, "patients aged": 0.15489782392978668, "elderly patients": 0.14801397919654846, "refractory cll": 0.1461126208305359, "lymphocytic leukemia": 0.1412508636713028, "cancer": 0.1368241161108017, "rh": 0.13359561562538147, "tg": 0.13299864530563354, "treatment": 0.11519365012645721, "cell therapy": 0.10176125913858414, "clinical": 0.10081004351377487, "chronic": 0.09970514476299286, "venetoclax plus": 0.08028772473335266, "leukemia": 0.07378311455249786, "ibrutinib": 0.07093948125839233, "trial": 0.059630878269672394, "jinxing capsule": 0.054070308804512024, "rituximab": 0.04426472261548042, "relapsed refractory": 0.042507678270339966, "relapsed": 0.04196525365114212, "about": 0.04014012962579727, "who": 0.032404158264398575, "jinxing": 0.03090626932680607, "imbruvica": 0.024282163009047508, "do": 0.022437116131186485, "efficacy": 0.021539539098739624, "cells": 0.02045579068362713, "risk": 0.019780606031417847, "may": 0.019505474716424942, "am": 0.018404759466648102, "but": 0.017386678606271744, "this": 0.013977104797959328, "more": 0.012369673699140549, "if you": 0.0099179707467556, "venetoclax": 0.00878266990184784, "or": 0.00783379003405571, "new": 0.007234099321067333, "capsule": 0.006777150556445122, "drug": 0.006137371063232422, "we": 0.004566717892885208, "lymphocytic": 0.004263792186975479, "that": -0.0008012847974896431}, "3": {"cell therapy": 0.4817171096801758, "car cell": 0.36470311880111694, "gene therapy": 0.3224988579750061, "lymphocytic leukemia": 0.29824355244636536, "cell": 0.2897329330444336, "cells": 0.2825523912906647, "relapsed refractory": 0.26335376501083374, "refractory cll": 0.26009976863861084, "therapy": 0.24598009884357452, "leukemia": 0.2367258071899414, "cancer": 0.19775176048278809, "cll": 0.18192246556282043, "refractory": 0.18052688241004944, "treatment": 0.16245579719543457, "relapsed": 0.15482667088508606, "car": 0.12016185373067856, "tg therapeutics": 0.11071597039699554, "chronic lymphocytic": 0.10785623639822006, "response": 0.1044849306344986, "lymphocytic": 0.09697651863098145, "efficacy": 0.08969713002443314, "can": 0.08156447112560272, "patients aged": 0.08077917248010635, "patients": 0.07638959586620331, "will": 0.06950251758098602, "chronic": 0.06568341702222824, "fda": 0.06031220406293869, "drug": 0.05498127639293671, "ibrutinib": 0.05392693728208542, "elderly patients": 0.05224865674972534, "study": 0.048556119203567505, "may": 0.046960391104221344, "dr": 0.03845291584730148, "amp nbsp": 0.037554532289505005, "do": 0.0334676057100296, "rh": 0.033437274396419525, "blood": 0.032533228397369385, "for": 0.03129349648952484, "tg": 0.02827790379524231, "jinxing capsule": 0.02497253194451332, "as": 0.019731707870960236, "it": 0.01865137368440628, "amp": 0.018036259338259697, "ginsenoside rh": 0.017340753227472305, "years": 0.015820208936929703, "with": 0.013096443377435207, "will be": 0.011501060798764229, "capsule": 0.010957171209156513, "data": 0.009487511590123177, "long term": 0.0066260648891329765}, "4": {"fda": 0.5913339853286743, "gene therapy": 0.3025553226470947, "cancer": 0.2854970693588257, "lymphocytic leukemia": 0.23341044783592224, "leukemia": 0.20702408254146576, "therapy": 0.1946127563714981, "cell therapy": 0.19251441955566406, "tg therapeutics": 0.18896037340164185, "cll": 0.17148038744926453, "drug": 0.1473235785961151, "treatment": 0.1328299641609192, "jinxing capsule": 0.12619051337242126, "chronic lymphocytic": 0.1166439950466156, "dr": 0.1051441878080368, "relapsed refractory": 0.09749779105186462, "refractory cll": 0.0869586318731308, "rituximab": 0.08655626326799393, "rh": 0.08366040885448456, "study": 0.08151237666606903, "relapsed": 0.07837288081645966, "patients aged": 0.071180060505867, "chronic": 0.06220925599336624, "clinical": 0.04600577428936958, "patients": 0.04443713650107384, "trial": 0.043873380869627, "capsule": 0.0434267558157444, "amp": 0.03907367214560509, "ibrutinib": 0.03125232458114624, "ginsenoside rh": 0.031092628836631775, "will be": 0.03016507439315319, "elderly patients": 0.02766156569123268, "cells": 0.027095913887023926, "jinxing": 0.023865140974521637, "be": 0.022679056972265244, "may": 0.016171801835298538, "will": 0.016157368198037148, "we": 0.013788524083793163, "blood": 0.011181635782122612, "you": 0.006634007208049297, "are": 0.0049778069369494915, "venetoclax": 0.0039920322597026825, "can": 0.003913251683115959, "efficacy": 0.0017067641019821167, "refractory": 0.00039662420749664307, "first": -7.726624608039856e-05, "amp nbsp": -0.0012822076678276062, "am": -0.00874539278447628, "tg": -0.009123371914029121, "new": -0.01051175408065319, "high": -0.011478286236524582}}